CELESTONE Safety Questions, CELESTONE Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about CELESTONE. Our extensive database of CELESTONE adverse events and CELESTONE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about CELESTONE
CELESTONE Safety Reports
Total CELESTONE reports: 28.CELESTONE FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 19.
Take CELESTONE Side Effects Survey or Share Your CELESTONE Story. CELESTONE Usage.
Physician from FRANCE reported CELESTONE problem on Dec 21, 2006. Female patient, 89 years of age, was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: antibody test positive, condition aggravated, erythema, pemphigoid. CELESTONE dosage: unknown. During the same period patient was treated with DIPROLENE, LEVOTHYROXINE, PERINDOPRIL ERBUMINE, LASIX. Patient was hospitalized. Patient recovered.
CELESTONE problem was reported by a Physician from JAPAN on Feb 02, 2007. Male patient, 72 years of age, was diagnosed with chronic sinusitis and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, haematuria, hepatic function abnormal, pruritus. CELESTONE dosage: unknown. During the same period patient was treated with CALBLOCK, DIOVAN, CLARITHROMYCIN, RIZABEN, MUCOSTA. Patient was hospitalized. Patient recovered.
Physician from RUSSIAN FEDERATION reported CELESTONE problem on Feb 15, 2007. Female patient, 18 years of age, was diagnosed with systemic lupus erythematosus and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: major depression, suicidal ideation. CELESTONE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAN, PLACVENILI. Patient recovered.
CELESTONE problem was reported by a Physician from JAPAN on Feb 20, 2007. Male patient, 72 years of age, weighting 165.3 lb, was diagnosed with chronic sinusitis, hypertension and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: chronic sinusitis, haematuria, hepatitis, nasal polyps. CELESTONE dosage: unknown. During the same period patient was treated with CLARITHROMYCIN, RIZABEN, MUCOSTA, DIOVAN. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported CELESTONE problem on Mar 23, 2007. Male patient, 13 years of age, was diagnosed with urticaria and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. CELESTONE dosage: unknown. During the same period patient was treated with ALLEGRA. Patient recovered.
CELESTONE problem was reported by a Consumer or non-health professional from FRANCE on Apr 12, 2007. Female patient, 22 years of age, was diagnosed with premature labour and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, lung disorder, sinus tachycardia. CELESTONE dosage: 12 MG; QD; IV. During the same period patient was treated with NICARDIPINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported CELESTONE problem on Nov 20, 2006. Female patient was diagnosed with foetal disorder, lung disorder and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: no adverse effect. CELESTONE dosage: unknown. During the same period patient was treated with CELESTONE SOLUSPAN. Patient was hospitalized. Patient recovered.
CELESTONE problem was reported by a Pharmacist from UNITED STATES on Oct 11, 2006. Female patient was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, incorrect dose administered. CELESTONE dosage: 60 MG; IM. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported CELESTONE problem on Mar 27, 2006. Female patient, 83 years of age, weighting 135.0 lb, was diagnosed with piriformis syndrome, arthralgia and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood glucose increased, convulsion, decreased activity, dizziness, headache, hypertension, hypotension, malaise. CELESTONE dosage: unknown. During the same period patient was treated with MARCAINE, HYDROCHLOROTHIAZIDE, VALIUM, PENICILLIN, KENALOG. Patient recovered.
CELESTONE problem was reported by a Physician from FRANCE on May 14, 2007. Female patient, 29 years of age, was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: erythema, tachycardia, vasodilatation. CELESTONE dosage: 6 MG;QD;IV. During the same period patient was treated with AUGMENTIN. Patient was hospitalized. Patient recovered.
Physician from PORTUGAL reported CELESTONE problem on May 04, 2007. Female patient, 49 years of age, was diagnosed with pain and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: eye swelling, feeling hot, lip swelling, swelling face. CELESTONE dosage: unknown. During the same period patient was treated with ALPRAZOLAM, WARFARIN, SERTRALINE, HYDROCHLORIDE, AMBROXOL, AMOXICILLIN. Patient was hospitalized. Patient recovered.
CELESTONE problem was reported by a Consumer or non-health professional from UNITED STATES on June 11, 2007. Female patient, weighting 160.0 lb, was diagnosed with sinusitis and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: chills, headache, injection site abscess, injection site nerve damage, injection site reaction, mobility decreased, pain, pyrexia. CELESTONE dosage: unknown. Patient recovered.
Physician from FRANCE reported CELESTONE problem on July 10, 2006. Female patient, 58 years of age, weighting 112.4 lb, was diagnosed with otitis media and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, lipase increased, pancreatic enlargement. CELESTONE dosage: 0.5 MG BID ORAL. Patient was hospitalized. Patient recovered.
CELESTONE problem was reported by a Physician from JAPAN on July 12, 2006. Female patient, 47 years of age, was diagnosed with dermatomyositis, interstitial lung disease and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, acute respiratory distress syndrome, aldolase increased, antinuclear antibody positive, cell marker increased, condition aggravated, cytomegalovirus chorioretinitis, depression, dermatomyositis. CELESTONE dosage: 3 MG QD ORAL. During the same period patient was treated with PREDONINE. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported CELESTONE problem on July 12, 2006. Male patient, child 1 years of age, weighting 22.05 lb, was diagnosed with laryngitis, rhinitis and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: arthritis bacterial, asthenia. CELESTONE dosage: unknown. Patient was hospitalized. Patient recovered.
CELESTONE problem was reported by a Physician from FRANCE on July 18, 2006. Female patient, 58 years of age, weighting 112.4 lb, was diagnosed with otitis media and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, lipase increased, pancreatic disorder. CELESTONE dosage: 0.5 MG BID ORAL. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported CELESTONE problem on July 13, 2006. Female patient, 26 years of age, weighting 132.3 lb, was diagnosed with joint sprain and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: anxiety, conversion disorder, diplegia, gait disturbance, muscular weakness, sensation of heaviness. CELESTONE dosage: unknown. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
CELESTONE problem was reported by a Physician from JAPAN on July 21, 2006. Female patient, 85 years of age, was diagnosed with rheumatoid arthritis and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: binocular eye movement disorder, blood beta-d-glucan increased, bone disorder, brain neoplasm, cataract, depressed level of consciousness, disorder of orbit, eyelid ptosis. CELESTONE dosage: 1 MG; ORAL. Patient died on 05/13/2005.
Physician from JAPAN reported CELESTONE problem on Sept 05, 2006. Male patient, 62 years of age, was diagnosed with asthma and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: cryptococcosis, diabetes mellitus. CELESTONE dosage: unknown. Patient recovered.
CELESTONE problem was reported by a Physician from FRANCE on Sept 18, 2006. Female patient, child 2 years of age, weighting 19.62 lb, was diagnosed with pneumonia and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: bullous lung disease, condition aggravated, infection, lung disorder, neutropenia, oxygen saturation decreased, pleural effusion, pneumothorax. CELESTONE dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported CELESTONE problem on Sept 18, 2006. Female patient, 66 years of age, was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: cheilitis, ocular icterus, palatal disorder, pharyngeal erythema, platelet count decreased, purpura, stevens-johnson syndrome. CELESTONE dosage: unknown. During the same period patient was treated with MYOLASTAN, ACETAMINOPHEN, CELEBREX. Patient was hospitalized. Patient recovered.
CELESTONE problem was reported by a Physician from JAPAN on Sept 21, 2006. Male patient, 13 years of age, weighting 127.9 lb, was diagnosed with rhinitis allergic and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: adrenal insufficiency, balance disorder, bone density decreased, failure to thrive, growth retardation, osteoporosis. CELESTONE dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported CELESTONE problem on Oct 05, 2006. Male patient, 29 years of age, was diagnosed with dermatitis allergic and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. CELESTONE dosage: unknown. During the same period patient was treated with ALESION. Patient recovered.
CELESTONE problem was reported by a Physician from UNITED STATES on Oct 05, 2006. Female patient, 70 years of age, weighting 200.0 lb, was diagnosed with back pain and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: arachnoiditis, hemiparesis, meningitis, radiculopathy. CELESTONE dosage: unknown. During the same period patient was treated with CELESTONE SOLUSPAN, LIDOCAINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CELESTONE problem on Oct 30, 2006. Female patient was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, incorrect dose administered, insulin resistance. CELESTONE dosage: unknown. Patient recovered.
CELESTONE problem was reported by a Health Professional from UNITED STATES on Oct 11, 2006. Female patient, 80 years of age, weighting 223.0 lb, was diagnosed with nerve block and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, muscle spasms, paralysis flaccid, paraparesis, post procedural complication, spinal cord oedema. CELESTONE dosage: 18 MG;ONCE;ED. During the same period patient was treated with LIDOCAINE HYDROCHLORIDE, METFORMIN, GLIPIZIDE, LORTAB, QUININE SULPHATE, LORAZEPAM, ATENOLOL, REGLAN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported CELESTONE problem on Nov 07, 2006. Female patient, 36 years of age, was diagnosed with back pain and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: anxiety, arthralgia, back pain, burning sensation, dysphagia, epstein-barr virus infection, flushing, gait disturbance. CELESTONE dosage: unknown. During the same period patient was treated with MARCAINE, MUSCLE RELAXANTS. Patient was hospitalized. Patient recovered.
CELESTONE problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2007. Female patient, 60 years of age, was diagnosed with osteoarthritis and was treated with CELESTONE. After drug was administered, patient experienced the following problems/side effects: abasia, abdominal distension, abdominal pain, agitation, aphonia, asthenia, back pain, cardiac disorder, chest discomfort. CELESTONE dosage: 2 ML;ONCE, 1 ML;ONCE. During the same period patient was treated with MINAX, SEREPAX, POLARAMINE, FEBRIDOL, PANALGESIC, ACETAMINOPHEN W. Patient recovered.
This
drug has an active FDA Safety Alert